TZLS-214

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug NameTZLS-214
Drug Alias NameTZLS-214OH-14
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionCASP8 and FADD-like apoptosis regulator inhibitorsApoptosis stimulants
TargetsCASP8 and FADD-like apoptosis regulator
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCardiff University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCardiff UniversityTiziana Life Sciences Plc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A